These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30315114)

  • 1. Deletion of
    Torok JA; Oh P; Castle KD; Reinsvold M; Ma Y; Luo L; Lee CL; Kirsch DG
    Cancer Res; 2019 Feb; 79(4):773-782. PubMed ID: 30315114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium.
    Moding EJ; Lee CL; Castle KD; Oh P; Mao L; Zha S; Min HD; Ma Y; Das S; Kirsch DG
    J Clin Invest; 2014 Aug; 124(8):3325-38. PubMed ID: 25036710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATM Inhibition Sensitizes Tumors to High-Dose Irradiation.
    Hallahan D
    Cancer Res; 2019 Feb; 79(4):704-705. PubMed ID: 30770366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitizing effects of miR-18a-5p on lung cancer stem-like cells via downregulating both ATM and HIF-1α.
    Chen X; Wu L; Li D; Xu Y; Zhang L; Niu K; Kong R; Gu J; Xu Z; Chen Z; Sun J
    Cancer Med; 2018 Aug; 7(8):3834-3847. PubMed ID: 29860718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of MicroRNA-195-5p on Biological Behaviors and Radiosensitivity of Lung Adenocarcinoma Cells via Targeting HOXA10.
    Yuan C; Bai R; Gao Y; Jiang X; Li S; Sun W; Li Y; Huang Z; Gong Y; Xie C
    Oxid Med Cell Longev; 2021; 2021():4522210. PubMed ID: 34925694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
    Toulany M; Mihatsch J; Holler M; Chaachouay H; Rodemann HP
    Radiother Oncol; 2014 May; 111(2):228-36. PubMed ID: 24857596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR Screen of Druggable Targets in Small Cell Lung Cancer Identified ATM Inhibitor (AZD1390) as a Radiosensitizer.
    Ran X; Wu BX; Shi M; Song L; Nixon K; Philip V; He HH; Tsao MS; Lok BH
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1308-1314. PubMed ID: 38104868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of the DNA damage response by transforming growth factor-beta inhibitors enhances radiation sensitivity of non-small-cell lung cancer cells in vitro and in vivo.
    Du S; Bouquet S; Lo CH; Pellicciotta I; Bolourchi S; Parry R; Barcellos-Hoff MH
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):91-9. PubMed ID: 25835621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition.
    Ding X; Cheng J; Pang Q; Wei X; Zhang X; Wang P; Yuan Z; Qian D
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):861-874. PubMed ID: 31419512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitizing the Vasculature of Primary Brainstem Gliomas Fails to Improve Tumor Response to Radiation Therapy.
    Deland K; Mercer JS; Crabtree DM; Guerra Garcia ME; Reinsvold M; Campos LDS; Williams NT; Luo L; Ma Y; Reitman ZJ; Becher OJ; Kirsch DG
    Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):771-779. PubMed ID: 34619331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells.
    Jette NR; Radhamani S; Arthur G; Ye R; Goutam S; Bolyos A; Petersen LF; Bose P; Bebb DG; Lees-Miller SP
    Br J Cancer; 2019 Oct; 121(7):600-610. PubMed ID: 31481733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor genotype dictates radiosensitization after Atm deletion in primary brainstem glioma models.
    Deland K; Starr BF; Mercer JS; Byemerwa J; Crabtree DM; Williams NT; Luo L; Ma Y; Chen M; Becher OJ; Kirsch DG
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 32990677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic reduction of vascular endothelial growth factor receptor 2 rescues aberrant angiogenesis caused by epsin deficiency.
    Tessneer KL; Pasula S; Cai X; Dong Y; McManus J; Liu X; Yu L; Hahn S; Chang B; Chen Y; Griffin C; Xia L; Adams RH; Chen H
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):331-337. PubMed ID: 24311377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapy.
    Moding EJ; Castle KD; Perez BA; Oh P; Min HD; Norris H; Ma Y; Cardona DM; Lee CL; Kirsch DG
    Sci Transl Med; 2015 Mar; 7(278):278ra34. PubMed ID: 25761890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK.
    Storozhuk Y; Hopmans SN; Sanli T; Barron C; Tsiani E; Cutz JC; Pond G; Wright J; Singh G; Tsakiridis T
    Br J Cancer; 2013 May; 108(10):2021-32. PubMed ID: 23632475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurora-A/NF-ĸB Signaling Is Associated With Radio-resistance in Human Lung Adenocarcinoma.
    Liu JB; Hu L; Yang Z; Sun YU; Hoffman RM; Yi Z
    Anticancer Res; 2019 Nov; 39(11):5991-5998. PubMed ID: 31704824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer.
    Cao C; Albert JM; Geng L; Ivy PS; Sandler A; Johnson DH; Lu B
    Cancer Res; 2006 Dec; 66(23):11409-15. PubMed ID: 17145887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models.
    Albert JM; Cao C; Geng L; Leavitt L; Hallahan DE; Lu B
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1536-43. PubMed ID: 16863930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining.
    Zhou Q; Howard ME; Tu X; Zhu Q; Denbeigh JM; Remmes NB; Herman MG; Beltran CJ; Yuan J; Greipp PT; Boughey JC; Wang L; Johnson N; Goetz MP; Sarkaria JN; Lou Z; Mutter RW
    Cancer Res; 2021 Jun; 81(12):3333-3346. PubMed ID: 33597272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation.
    Klein C; Dokic I; Mairani A; Mein S; Brons S; Häring P; Haberer T; Jäkel O; Zimmermann A; Zenke F; Blaukat A; Debus J; Abdollahi A
    Radiat Oncol; 2017 Dec; 12(1):208. PubMed ID: 29287602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.